Proximal and distal gastro-oesophageal reflux in chronic obstructive pulmonary disease and bronchiectasis

Respirology

Volumn 19, Issue 2, 2014, Pages 211-217

  Lee, Annemarie L ^a,c   Button, Brenda M ^c,d,e   Denehy, Linda ^a   Roberts, Stuart J ^c,d   Bamford, Tiffany L ^d,f   Ellis, Samantha J ^c   Mu, Fi Tjen ^d   Heine, Ralf G ^b,g   Stirling, Robert G ^d,e   Wilson, John W ^d,e  

^a THE UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c Department of Physiotherapy ^*  (Australia)

^d MONASH UNIVERSITY   (Australia)

^e ALFRED HOSPITAL   (Australia)

^f Janssen Pharmaceuticals Johnson and Johnson   (Australia)

^g ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

bronchiectasis; chronic obstructive pulmonary disease; gastro oesophageal reflux; quality of life

Indexed keywords

PEPSIN A;

ADULT; AGED; ARTICLE; BRONCHIECTASIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE SEVERITY; ESOPHAGEAL PH MONITORING; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GASTRIC SUCTION; GASTROESOPHAGEAL REFLUX; HUMAN; LUNG DISEASE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SPUTUM ANALYSIS; THORAX RADIOGRAPHY; COMPLICATION; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

ADULT; AGED; BRONCHIECTASIS; ESOPHAGEAL PH MONITORING; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84892623105     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12182     Document Type: Article

References (50)

1. Weycker D, Edelsberg J, Oster G, et al. Prevalence and economic burden of bronchiectasis. Clin. Pulm. Med. 2005; 12: 205-209.
2. Ekberg-Aronssonm M, Pehrsson K, Nilsson J, et al. Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis. Respir. Res. 2005; 6: 98-106.
3. Divo M, Cote C, de Torres JP, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2012; 186: 155-161.
4. Chang A, Bilton D,. Exacerbations of cystic fibrosis: 4 non-cystic fibrosis bronchiectasis. Thorax 2008; 63: 269-276.
5. Kiljander T, Laitinen JO,. The prevalence of gastroesophageal reflux disease in adult asthmatics. Chest 2004; 126: 1490-1494.
6. Button BM, Roberts S, Kotsimbos TC, et al. Gastroesophageal reflux (symptomatic and silent): a potentially significant problem in patients with cystic fibrosis before and after lung transplantation. J. Heart Lung Transplant. 2005; 24: 1522-1529.
7. Blondeau K, Dupont L, Mertens V, et al. Gastroesophageal reflux and aspiration of gastric contents in adult patients with cystic fibrosis. Gut 2008; 57: 1049-1055.
8. Raghu G, Freudenberger T, Yang S, et al. High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis. Eur. Respir. J. 2006; 27: 136-142.
9. Sweet M, Patti M, Hoopes C, et al. Gastro-oesophageal reflux and aspiration in patients with advanced lung disease. Thorax 2009; 64: 167-173.
10. Casanova C, Baudet J, del Valle Velasco M, et al. Increased gastro-oesophageal reflux disease in patients with severe COPD. Eur. Respir. J. 2004; 23: 841-845.
11. Orr W, Shamma-Othman Z, Allen M, et al. Esophageal function and gastroesophageal reflux during sleep and waking in patients with chronic obstructive pulmonary disease. Chest 1992; 101: 1521-1525.
12. Kempainen R, Savik K, Whelan T, et al. High prevalence of proximal and distal gastroesophageal reflux disease in advanced COPD. Chest 2007; 131: 1666-1671.
13. Mokhlesi B, Morris A, Huang C-F, et al. Increased prevalence of gastroesophageal reflux symptoms in patients with COPD. Chest 2001; 119: 1043-1048.
14. Rascon-Aguilar I, Pamer M, Wludyka P, et al. Role of gastroesophageal reflux symptoms in exacerbations of COPD. Chest 2006; 130: 1096-1101.
15. Niklasson A, Strid H, Simren M, et al. Prevalence of gastrointestinal symptoms in patients with chronic obstructive pulmonary disease. Eur. J. Gastroenterol. Hepatol. 2008; 20: 335-341.
16. Sweet M, Herbella F, Leard L, et al. The prevalence of distal and proximal gastroesophageal reflux in patients awaiting lung transplantation. Ann. Surg. 2006; 244: 491-497.
17. Kamble N, Khan N, Kumar N, et al. Study of gastro-oesophageal reflux disease in patients with mild-to-moderate chronic obstructive pulmonary disease in India. Respirology 2013; 18: 463-467.
18. Farrell S, McMaster C, Gibson D, et al. Pepsin in bronchoalveolar lavage fluid: a specific and sensitive method of diagnosing gastro-oesophageal reflux-related pulmonary aspiration. J. Pediatr. Surg. 2006; 41: 289-293.
19. Potluri S, Friedenberg F, Parkman H, et al. Comparison of a salivary/sputum pepsin assay with 24-hour esophageal pH monitoring for detection of gastric reflux into the proximal esophagus, oropharynx and lung. Dig. Dis. Sci. 2003; 48: 1813-1817.
20. Kennedy J,. 'Silent' gastroesophageal reflux: an important but little known cause of pulmonary complications. Dis. Chest 1962; 42: 42-445.
21. Koh W, Lee J, Kwon Y, et al. Prevalence of gastroesophageal reflux disease in patients with nontuberculous mycobacterial lung disease. Chest 2007; 131: 1825-1830.
22. Ward C, Forrest I, Brownlee I, et al. Pepsin like activity in bronchoalveolar lavage fluid is suggestive of gastric aspiration in lung allografts. Thorax 2005; 60: 872-874.
23. Stovold R, Forrest I, Corris P, et al. Pepsin, a biomarker of gastric aspiration in lung allografts. A putative association with rejection. Am. J. Respir. Crit. Care Med. 2007; 175: 1298-1303.
24. Starosta V, Kitz R, Hartl D, et al. Bronchoalveolar pepsin, bile acids, oxidation and inflammation in children with gastroesophageal reflux disease. Chest 2007; 132: 1557-1564.
25. Blondeau K, Mertens V, Vanaudenaerde B, et al. Acid, non-acid GER and gastric aspiration in lung transplant patients with or without chronic rejection. Eur. Respir. J. 2008; 31: 707-713.
26. Ducolone A, Vandevenne A, Jouin H, et al. Gastroesophageal reflux in patients with asthma and chronic bronchitis. Am. Rev. Respir. Dis. 1987; 135: 327-332.
27. Tsang K, Lam W-K KE, et al. Helicobacter pylori and upper gastrointestinal symptoms in bronchiectasis. Eur. Respir. J. 1999; 14: 1345-1350.
28. Rabe KF, Hurd S, Anzueto A, et al. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Crit. Care Med. 2007; 176: 532-555.
29. Bhalla M, Turcios N, Aponte V, et al. Cystic fibrosis: scoring system with thin-section CT. Radiology 1991; 179: 783-788.
30. Bousquet J, Clark TJ, Hurd S, et al. GINA guidelines for asthma and beyond. Allergy 2007; 62: 102-112.
31. Kahrilas P, Quigley E,. Clinical esophageal pH recording: a technical review for practice guideline development. Gastroenterol. 1996; 110: 1981-1996.
32. Wolfe M, Sachs G,. Acid suppression: optimizing therapy for gastroduodenal ulcer healing, gastroesophageal reflux disease and stress-related erosive syndrome. Gastroenterology 2000; 118: S9-S31.
33. Carlsson R, Dent J, Bolling-Sternevald E, et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand. J. Gastroenterol. 1998; 33: 1023-1029.
34. Mones J, Clave P, Mearin F,. Esophageal pH monitoring: are you sure that the electrode is properly placed? Am. J. Gastroenterol. 2001; 96: 975-978.
35. Pehl C, Boccali I, Hennig M, et al. pH probe positioning for 24-hour pH-metry by manometry or pH step-up. Eur. J. Gastroenterol. Hepatol. 2004; 16: 375-382.
36. Jamieson J, Stein H, DeMeester T, et al. Ambulatory 24-H esophageal pH monitoring: normal values, optimal thresholds, specificity, sensitivity and reproducibility. Am. J. Gastroenterol. 1992; 87: 1102-1111.
37. Dobhan R, Castell D,. Normal and abnormal proximal esophageal acid exposure: results of ambulatory dual-probe pH monitoring. Am. J. Gastroenterol. 1993; 88: 25-29.
38. Krishna U, Mitchell JD, Messina I, et al. Assay of tracheal pepsin as a marker for reflux aspiration. J. Paediatr. Gastroenterol. Nutr. 2002; 35: 303-308.
39. Tasker A, Dettmar P, Panetti M, et al. Is gastric reflux a cause of otitis media with effusion in children? Laryngoscope 2002; 112: 1930-1934.
40. Dent J, El-Serag H, Wallander M, et al. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005; 54: 710-717.
41. Johnson L, DeMeester T,. Twenty-four monitoring of the distal esophagus: a quantitative measure of gastroesophageal reflux. Am. J. Gastroenterol. 1974; 62: 325-332.
42. Masclee A, De Best A, de Graaf R, et al. Ambulatory 24-hour pH-metry in the diagnosis of gastroesophageal reflux disease. Scand. J. Gastroenterol. 1990; 25: 225-230.
43. Richter J, Bradley L, DeMeester T, et al. Normal 24-hr ambulatory esophageal pH values. Influence of study centre, pH electrode, age and gender. Dig. Dis. Sci. 1992; 37: 849-864.
44. Schindlbeck N, Henrich C, Konig A, et al. Optimal thresholds, sensitivity and specificity of long-term pH-metry for the detection of gastroesophageal reflux disease. Gastroenterology 1987; 93: 85-90.
45. Lee J, Anggiansah A, Anggiansah R, et al. Effects of age on the gastroesophageal junction, esophageal motility and reflux disease. Clin. Gastroenterol. Hepatol. 2007; 5: 1392-1398.
46. Decalmer S, Stovold R, Houghton L, et al. Chronic cough: relationship between microaspiration, gastroesophageal reflux and cough frequency. Chest 2012; 142: 958-964.
47. Samuels T, Johnston N,. Pepsin as a marker of extraesophageal reflux. Ann. Otol. Rhinol. Laryngol. 2010; 119: 203-208.
48. Takada K, Matsumoto S, Kojima E, et al. Prospective evaluation of the relationship between acute exacerbations of COPD and gastroesophageal reflux disease diagnosed by questionnaire. Respir. Med. 2011; 105: 1531-1536.
49. Terada K, Muro S, Sato S, et al. Impact of gastro-oesophageal reflux disease symptoms on chronic obstructive pulmonary disease exacerbation. Thorax 2008; 63: 951-955.
50. McNally P, Ervine E, Shields MD, et al. High concentrations of pepsin in bronchoalveolar lavage fluid from children with cystic fibrosis are associated with high interleukin-8 concentrations. Thorax 2011; 66: 140-143.